Frederic Bernard, based in Germany, is currently a Global Program Head Neurology and Immunology, Mavenclad and Cladribine at Merck KGaA, Darmstadt, Germany. Frederic Bernard brings experience from previous roles at Merck KGaA, Darmstadt, Germany and EMD Serono, Inc.. Frederic Bernard holds a 2000 - 2003 PhD in Neuroscience @ University of Strasbourg. With a robust skill set that includes In Vivo, Drug Discovery, Pharmacology, Animal Models, Neurodegenerative Diseases and more. Frederic Bernard has 2 emails on RocketReach.
Looking for a different Frederic Bernard?
Find contact details for 700 million professionals.